Curis
CRIS
$14.47
Share price
-0.34%
Change (1 day)
1,731.65%
Change (1 year)
Categories
Curis (CRIS) - Total assets
Total assets on the balance sheet as of December 2023 : $77.28 M
According to Curis's latest financial reports the company's total assets are $77.28 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Curis - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $77.28 M | -29% |
| 2022-12-31 | $0.10 B | -32.93% |
| 2021-12-31 | $0.16 B | -20.58% |
| 2020-12-31 | $0.20 B | 482.1% |
| 2019-12-31 | $35.1 M | -6.04% |
| 2018-12-31 | $37.36 M | -49.37% |
| 2017-12-31 | $73.79 M | 27.78% |
| 2016-12-31 | $57.75 M | -39.19% |
| 2015-12-31 | $94.96 M | 51.67% |
| 2014-12-31 | $62.61 M | -22.31% |
| 2013-12-31 | $80.59 M | 15.51% |
| 2012-12-31 | $69.76 M | 44.81% |
| 2011-12-31 | $48.18 M | -4.87% |
| 2010-12-31 | $50.64 M | 40.31% |
| 2009-12-31 | $36.09 M | -9.71% |
| 2008-12-31 | $39.98 M | -25.71% |
| 2007-12-31 | $53.81 M | 2.96% |
| 2006-12-31 | $52.26 M | -14.19% |
| 2005-12-31 | $60.91 M | -9.53% |
| 2004-12-31 | $67.33 M | 20.8% |
| 2003-12-31 | $55.73 M | -10.74% |
| 2002-12-31 | $62.44 M | -56.86% |
| 2001-12-31 | $0.14 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $226.50 B | 292,983.77% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $95.15 B | 123,032.17% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | $0.10 B | 39.33% | 🇺🇸 USA |
 Exelixis EXEL | $2.94 B | 3,707.30% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.46 B | 502.50% | 🇺🇸 USA |
 Cel-Sci
CVM | $28.71 M | -62.85% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $1.82 B | 2,259.15% | 🇺🇸 USA |